Trump’s tariffs and trade war continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

The Vanguard S&P 500 ETF (NYSEMKT: VOO) closed at a new all-time high Thursday, 577.18, and seems to be aiming for a repeat Friday, rising 0.2% in premarket trading. With most of the week's macroeconomic and tariffs news now in the rear view mirror,

Palantir (NASDAQ: PLTR) stock saw a massive rally across the first half of 2025's trading. The tech company's share price rose 80.3% across the stretch against the backdrop of a 5.5% gain for the S&P 500 index, according to data from S&P Global Market Intelligence

Trump’s tariffs and trade war continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

The IPO Pulse actually peaked last October and has been slowing since then. But the downturn certainly accelerated in March and April as the stock market sold off, with the IPO Pulse falling to a 1½-year low in April (chart below, blue line).

Among the stocks on the move Friday were Coinbase Global COIN, Robinhood Markets and Tesla. Coinbase shares climbed more than 4%, while Robinhood stock advanced more than 6%. Tesla stock moved up 1.6%, testing resistance at the 50-day moving average line.

US Stock market today ended higher as the Dow Jones, S&P 500, and Nasdaq all posted modest gains amid upbeat earnings reports and a surprise jump in retail sales. Investors are cautiously optimistic despite political tension as President Trump continues pressuring Fed Chair Jerome Powell over interest rate cuts.

Palantir's expansion into commercial markets has boosted its business. The stock has been on a tear since the start of 2024. Palantir's valuation is sky-high.

Strategy's advantage is that it can invest in other cryptocurrencies. While right now, its focus is clearly to load up on Bitcoins, it may not stay that way forever. If there are changing market conditions in crypto, it has the freedom to diversify or pivot to other assets.

A little-known Nasdaq-listed drugmaker plans to invest $100M in litecoin, appoints Charlie Lee to its board and names GSR as treasury manager.